The regulation of sequential processing of HIV-1 gag by the viral protease

被引:0
|
作者
Pettit, SC
Sheng, NJ
Tritch, R
Erickson-Viitanen, S
Swanstrom, R [1 ]
机构
[1] Dupont Merck Pharmaceut Co, Lineberger Comprehens Canc Ctr, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Dept Mol Biol, Wilmington, DE 19880 USA
[3] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:15 / 25
页数:11
相关论文
共 50 条
  • [41] Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism
    Louis, JM
    Wondrak, EM
    Kimmel, AR
    Wingfield, PT
    Nashed, NT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23437 - 23442
  • [42] Ubiquitination of HIV-1 and MuLV Gag
    Ott, DE
    Coren, LV
    Chertova, EN
    Gagliardi, TD
    Schubert, U
    VIROLOGY, 2000, 278 (01) : 111 - 121
  • [43] Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) gag p7NC and the C-cleavage site impact Gag-Pol processing by HIV-1 protease
    Goodenow, MM
    Bloom, G
    Rose, SL
    Pomeroy, SM
    O'Brien, PO
    Perez, EE
    Sleasman, JW
    Dunn, BM
    VIROLOGY, 2002, 292 (01) : 137 - 149
  • [44] The stoichiometry of Gag protein in HIV-1
    Briggs, JAG
    Simon, MN
    Gross, I
    Kräusslich, HG
    Fuller, SD
    Vogt, VM
    Johnson, MC
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (07) : 672 - 675
  • [45] Assessment of the population coverage of an HIV-1 vaccine targeting sequences surrounding the viral protease cleavage sites in Gag, Pol, or all 12 protease cleavage sites
    Daniel, Mathew
    Liang, Binhua
    Luo, Ma
    VACCINE, 2021, 39 (19) : 2676 - 2683
  • [46] Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor
    Ho, Sarah K.
    Perez, Elena E.
    Rose, Stephanie L.
    Coman, Roxana M.
    Lowe, Amanda C.
    Hou, Wei
    Ma, Changxing
    Lawrence, Robert M.
    Dunn, Ben M.
    Sleasman, John W.
    Goodenow, Maureen M.
    AIDS, 2009, 23 (13) : 1631 - 1640
  • [47] Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
    Wright, J. K.
    Brockman, M. A.
    Brumme, Z. L.
    Walker, B. D.
    Goulder, P. J.
    Ndung'u, T.
    RETROVIROLOGY, 2009, 6
  • [48] HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag
    Yu, Fu-Hsien
    Huang, Kuo-Jung
    Wang, Chin-Tien
    VIRUSES-BASEL, 2020, 12 (01):
  • [49] Allosteric regulation of an HIV-1 protease inhibitor by ZnII ions
    Valente, S
    Gobbo, M
    Licini, G
    Scarso, A
    Scrimin, P
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2001, 40 (20) : 3899 - +
  • [50] Regulation of HIV-1 protease activity through cysteine modification
    Davis, DA
    Dorsey, K
    Wingfield, PT
    Stahl, SJ
    Kaufman, J
    Fales, HM
    Levine, RL
    BIOCHEMISTRY, 1996, 35 (07) : 2482 - 2488